Tencent

Activity from announced rounds

All recorded activity

Tencent is the corporate investor identified as lead in Circle Games and W4 financing material.

Recorded funding activity

Circle develops mobile puzzle games. W4 supports studios using Godot, while Lovable develops software-creation tools. The records preserve corporate attribution and distinguish published from draft relationships.

Sources
Rounds participated in
10
Confirmed lead rounds
2
7 roles undisclosed
New companies
10
First participation on record · 0 follow-on
Funding in participating rounds
$952.3M
10 disclosed · full round size, not this investor’s share

By stage

Undisclosed4
Series C+3
Series B2
Series A1

By primary sector

Fintech3
Healthtech2
AI1
Biotech1
Developer tools1
2 more
Hardware1
Media & gaming1

By country

China3
United Kingdom2
Germany1
Ireland1
Sweden1
2 more
Turkey1
United States1

Rounds

10 in all activity
Circle Games

Circle Games develops mobile puzzle games built around simple interactions, colorful boards and increasingly challenging levels.

$25MSeries A
Lead
W4 Games

Commercial tools and engineering services that help game studios build, optimize and ship projects made with the Godot Engine.

$18MSeries B
Lead
Lovable

Lovable helps people build software by describing what they want to an AI development platform.

$400MSeries C
Participant
Even Realities

Develops display-first smart glasses with augmented reality features

$150MUndisclosed
Role not disclosed
SignalPlus

Provides institutional digital assets options and derivatives trading infrastructure

$50MSeries B1
Role not disclosed
Primer

Unified infrastructure for global payments

$100MSeries C
Role not disclosed
StairMed

Develops minimally invasive implantable brain-machine interfaces (BMI) for neurological diseases

CN¥500MStrategic
Role not disclosed
Upvest

Provides API-based infrastructure for securities businesses

$125MUndisclosed
Role not disclosed
Brainomix

Develops AI-powered imaging tools for stroke and lung fibrosis

$6.8MSeries C+
Role not disclosed
Insilico Medicine

Develops AI-driven drug discovery and oncology treatments

$5MStrategic
Role not disclosed